Drugs / BIAsp50
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00888732 | Jun 2009 → Jun 2010 | type 1 diabetes mellitus | University of Aarhus | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00283218 | Jan → Aug 2006 | type 1 diabetes mellitus | University of Aarhus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIAsp 50 | “The profiles will be derived over a 12-hour period after subcutaneous injection in the abdominal region with a single dose of IAsp, BIAsp 30, BIAsp 50 or BIAsp 70 at a test meal.” NCT00283218 ↗ |
| Route | Subcutaneous | “after subcutaneous injection in the abdominal region with a single dose of IAsp, BIAsp 50, BIAsp 70 or Fast-acting Human Insulin” NCT00888732 ↗ |